Abstract:Fukuyama-type congenital muscular dystrophy (FCMD), one of the most common autosomal recessive disorders in the Japanese population, is characterized by congenital muscular dystrophy in combination with cortical dysgenesis (micropolygyria). Recently, we identified, on chromosome 9q31, the gene responsible for FCMD, which encodes a novel 461 amino acid protein which we have termed fukutin. Most FCMD-bearing chromosomes examined to date (87%) have been derived from a single ancestral founder, whose mutation cons… Show more
“…In comparison with our study, systematic analysis of the FCMD gene in 107 unrelated patients by Kondo-Iida et al (1999) revealed that 80 probands (75%) were homozygous for the 3 kb insertion, 25 (23%) were heterozygous, and two did not show the 3 kb insertion on either allele. In our study, however, the number of homozygotes and heterozygotes was almost the same.…”
Section: Phenotype-genotype Relationship In Fcmd After Discovery Of Fcontrasting
confidence: 73%
“…According to the report by Kondo-Iida et al (1999), among patients homozygous for the founder mutation, 91.5% showed milder (stand or walk with or without support) or typical (able to sit unassisted or to slide on buttocks) phenotypes, and only 2.5% of cases were classified as severe (could sit only with support or had no head control), while among patients with heterozygous for the founder mutation, 92% showed severe phenotypes. This was true in our study, as most homozygotes could sit without help, while half of the heterozygotes were bedridden.…”
Section: Phenotype-genotype Relationship In Fcmd After Discovery Of Fmentioning
“…In comparison with our study, systematic analysis of the FCMD gene in 107 unrelated patients by Kondo-Iida et al (1999) revealed that 80 probands (75%) were homozygous for the 3 kb insertion, 25 (23%) were heterozygous, and two did not show the 3 kb insertion on either allele. In our study, however, the number of homozygotes and heterozygotes was almost the same.…”
Section: Phenotype-genotype Relationship In Fcmd After Discovery Of Fcontrasting
confidence: 73%
“…According to the report by Kondo-Iida et al (1999), among patients homozygous for the founder mutation, 91.5% showed milder (stand or walk with or without support) or typical (able to sit unassisted or to slide on buttocks) phenotypes, and only 2.5% of cases were classified as severe (could sit only with support or had no head control), while among patients with heterozygous for the founder mutation, 92% showed severe phenotypes. This was true in our study, as most homozygotes could sit without help, while half of the heterozygotes were bedridden.…”
Section: Phenotype-genotype Relationship In Fcmd After Discovery Of Fmentioning
“…This insertion, which occurs in the 3' untranslated region of the gene, causes reduced expression of normal fukutin protein, resulting in a milder phenotype than would occur from a null mutation. Once compound heterozygotes were identified, the clinical spectrum was expanded to include ocular defects and a poorer prognosis, 24 and homozygous nonsense mutations were shown to yield WWS. 25 Likewise, mutations in POMT1 were originally reported only to give rise to WWS, which presents with the most severe clinical features of all the dystroglycanopathies (the average life expectancy of WWS patients is 0.8 years).…”
Section: The Dystroglycanopathies: Clinical and Genetic Findingsmentioning
SUMMARYRecent studies have defined a group of muscular dystrophies, now termed the dystroglycanopathies, as novel disorders of glycosylation. These conditions include Walker-Warburg syndrome, muscleeye-brain disease, Fukuyama-type congenital muscular dystrophy, congenital muscular dystrophy types 1C and 1D, and limb-girdle muscular dystrophy type 2I. Although clinical findings can be highly variable, dystroglycanopathies are all characterized by cortical malformations and ocular defects at the more severe end of the clinical spectrum, in addition to muscular dystrophy. All of these disorders are defined by the underglycosylation of α-dystroglycan. Defective glycosylation of dystroglycan severs the link between this important cell adhesion molecule and the extracellular matrix, thereby contributing to cellular pathology. Recent experiments indicate that glycosylation might not only define forms of muscular dystrophy but also provide an avenue to the development of therapies for these disorders.
“…51) Fukutin (FKTN, 607440) is essential for the protein complex between dystrophin and dystroglycan, to preserve glycosyltransferase activity, and fukutin-related protein (FKRP, 606596) can regulate the post-translational modification of dystroglycan. [52][53][54] Missense mutations such as Q358P and R179T mutations in the FKTN gene, as well as insertion of a 3,062-bp transposon situated in the 3-prime untranslated region of the FKTN gene, can cause a less diagnosed form of idiopathic dilated cardiomyopathy and congestive heart failure [52][53][54] Mutations in the FKRP gene cause a phenotypic spectrum arising from limb-girdle muscular dystrophy with dcM. 15,55,56) 4.…”
Cardiomyopathies are defined as cardiac diseases of the myocardium with associated cardiac dysfunction. They are cardiac diseases in which heart muscle disease and/or measurable deterioration of cardiac muscle function occurs due to various causes, such as genetic and sporadic mutations of muscle proteins, as well as external factors such as hypertension, ischemia, and inflammation. In 1995, the WHO/International Society and Federation of Cardiology (ISFC) classified primary cardiomyopathy caused by intrinsic factors into five groups according to the dominant pathophysiology: dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restricted cardiomyopathy (RCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), and unclassified cardiomyopathy. Among these cardiomyopathies, DCM is the most prevalent and the most common reason for cardiac transplantation in adults and children. Many recent findings indicate that genetic and sporadic mutations of a number of muscle proteins, such as myofibrillar, structural, and Ca 2+ regulating proteins, can cause DCM. In such cases, certain mutations often induce DCM with cardiac arrhythmia that is recognized as a potential trigger of sudden cardiac death. Thus, effective prognostic determination and appropriate cardiac care depend on accurate molecular and genetic diagnoses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.